Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call reveals a significant decline in revenue (85% YoY) and increased operating and net losses. Despite the strategic shift to a broker-dealer model, the absence of a share buyback program and the increased financial losses overshadow the potential benefits of FINRA approval. The market remains uncertain, and no positive catalysts were announced to offset these concerns. The lack of Q&A further indicates potential investor apprehension, leading to a strong negative sentiment.
Revenue $152,682 (decreased by $890,111 or approximately 85% year-over-year) due to the lack of consulting service revenue for equity securities in Q3 2025, compared to $1,042,793 in Q3 2024.
Operating Loss $1,687,692 (increased from a loss of $1,205,157 year-over-year) reflecting ongoing challenges and the shift in focus towards establishing the broker-dealer subsidiary.
Net Loss $3,006,537 (increased from a net loss of approximately $2.2 million year-over-year) impacted by an impairment charge of $1.3 million for one of the portfolio companies.
Net Loss per Share $1.57 EPS (compared to a loss of $13.60 EPS for the same period in the prior year) reflecting the overall increase in net loss.
Market Expansion: Netcapital Securities, Inc. (NSI) has become a broker-dealer, approved by FINRA, allowing it to handle private placements, support companies raising equity capital under Reg A and Reg D, and partner with other broker-dealers.
Operational Efficiency: The company reported an operating loss of $1,687,692 for Q3 2025, an increase from the operating loss of $1,205,157 in Q3 2024.
Strategic Shift: Management has shifted focus towards establishing Netcapital Securities as a broker-dealer and has not pursued equity-based revenue contracts.
Revenue Decline: Revenues decreased by $890,111 (approximately 85%) to $152,682 compared to $1,042,793 in Q3 2024, attributed to the lack of consulting service revenue for equity securities.
Operating Loss: Reported an operating loss of $1,687,692 for Q3 2025, compared to an operating loss of $1,205,157 in Q3 2024.
Net Loss: Net loss for Q3 2025 was approximately $3,006,537, compared to a net loss of approximately $2.2 million in the same period of the prior year.
Impairment Charge: Included an impairment charge of $1.3 million for one of the portfolio companies.
Market Environment: Management noted that the market environment remains uncertain, which poses a risk to future performance.
Regulatory Approval: While the approval of the broker-dealer subsidiary (Netcapital Securities, Inc.) is a positive development, it also introduces regulatory compliance risks associated with operating as a broker-dealer.
Broker-Dealer Subsidiary: Management has progressed on establishing our broker-dealer subsidiary, Netcapital Securities, Inc., which received FINRA approval on November 22, 2024.
Revenue Generation: Netcapital Securities, Inc. is now approved to handle private placements of securities, support companies raising equity capital under Reg A and Reg D, and partner with other broker-dealers.
Client Engagement: GenOn Neuroscience, Inc. has engaged Netcapital Securities for broker-dealer and administrative services for a planned Regulation A offering.
Revenue Outlook: Management remains cautiously optimistic about future revenue generation through the broker-dealer subsidiary despite current market uncertainties.
Financial Performance: The company reported a net loss of approximately $3,006,537 for Q3 2025, with a focus on improving financial performance through new revenue streams.
Operating Loss: An operating loss of $1,687,692 was reported for Q3 2025, compared to a loss of $1,205,157 in Q3 2024.
Share Buyback Program: None
The earnings call reveals significant challenges: a drastic revenue decline, ongoing operating losses, and strategic execution risks. While the company is optimistic about its fintech and tokenized asset strategy, the lack of current revenues from key initiatives and unclear management responses raise concerns. The Q&A section highlights skepticism from analysts, particularly regarding acquisitions and revenue generation. Despite some positive developments like improved loss per share, the overall sentiment is negative due to financial struggles and strategic uncertainties.
The earnings call reveals concerns such as a high revenue concentration risk, increased operating loss, and execution risks associated with a strategic shift. Despite a 34% revenue growth, the dependency on a single client and rising losses are troubling. The lack of clear responses in the Q&A section further adds uncertainty. These factors, combined with regulatory risks in blockchain and crypto, suggest a negative sentiment. However, the absence of market cap data limits the assessment of stock volatility.
The earnings call reveals a significant decline in revenue (85% YoY) and increased operating and net losses. Despite the strategic shift to a broker-dealer model, the absence of a share buyback program and the increased financial losses overshadow the potential benefits of FINRA approval. The market remains uncertain, and no positive catalysts were announced to offset these concerns. The lack of Q&A further indicates potential investor apprehension, leading to a strong negative sentiment.
The earnings call reveals significant revenue decline, unrealized losses, and operational losses, despite some growth in portal fees. The Q&A section shows management's lack of clarity on future growth initiatives. The application for a broker-dealer license could potentially improve revenue, but current financial struggles and competitive pressures overshadow this. Overall, the negative financial performance and uncertain strategic direction suggest a negative stock price movement.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.